# Pedevco Corp: financial statements, quarterly

PED · NYSE · CIK 1141197 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ped.md) · [Financials](/companies/ped/financials.md) · [Filings](/companies/ped/filings.md) · [Insiders](/companies/ped/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ped/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7.3](/filings/0001654954-24-014468.md) | [6.7 d](/filings/0001654954-25-012381.md) | [8.1](/filings/0001654954-25-005762.md) | [11.8](/filings/0001654954-25-009652.md) | [9.1](/filings/0001654954-25-013092.md) | [10.6 d](/filings/0001654954-26-003098.md) | [8.7](/filings/0001654954-26-004891.md) | [7.0](/filings/0001654954-26-007591.md) | [7.0](/filings/0001654954-25-013092.md) | [23.1 d](/filings/0001654954-26-003098.md) | [40.2](/filings/0001654954-26-004891.md) | [46.1](/filings/0001654954-26-007591.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [1.3](/filings/0001654954-24-014468.md) | [1.9 d](/filings/0001654954-25-012381.md) | [1.5](/filings/0001654954-25-005762.md) | [1.4](/filings/0001654954-25-009652.md) | [1.3](/filings/0001654954-25-013092.md) | [2.2 d](/filings/0001654954-26-003098.md) | [1.6](/filings/0001654954-26-004891.md) | [1.7](/filings/0001654954-26-007591.md) | [1.5](/filings/0001654954-25-013092.md) | [12.0 d](/filings/0001654954-26-003098.md) | [3.1](/filings/0001654954-26-004891.md) | [3.4](/filings/0001654954-26-007591.md) |
| Operating income | $m | [0.9](/filings/0001654954-24-014468.md) | [(2.7) d](/filings/0001654954-25-012381.md) | [0.6](/filings/0001654954-25-005762.md) | [2.6](/filings/0001654954-25-009652.md) | [2.8](/filings/0001654954-25-013092.md) | [(1.4) d](/filings/0001654954-26-003098.md) | [0.2](/filings/0001654954-26-004891.md) | [(2.2)](/filings/0001654954-26-007591.md) | [(0.8)](/filings/0001654954-25-013092.md) | [(4.9) d](/filings/0001654954-26-003098.md) | [6.7](/filings/0001654954-26-004891.md) | [15.4](/filings/0001654954-26-007591.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001654954-25-013092.md) | [0.0 d](/filings/0001654954-26-003098.md) | [0.0](/filings/0001654954-26-004891.md) | [0.0](/filings/0001654954-26-007591.md) | [0.1](/filings/0001654954-25-013092.md) | [1.3 d](/filings/0001654954-26-003098.md) | [2.0](/filings/0001654954-26-004891.md) | [2.0](/filings/0001654954-26-007591.md) |
| Income tax | $m | not reported | not reported | [0.0](/filings/0001654954-25-005762.md) | [0.0](/filings/0001654954-25-009652.md) | [0.0](/filings/0001654954-25-013092.md) | [(7.3) d](/filings/0001654954-26-003098.md) | [0.1](/filings/0001654954-26-004891.md) | [(0.5)](/filings/0001654954-26-007591.md) | [(0.2)](/filings/0001654954-25-013092.md) | [8.6 d](/filings/0001654954-26-003098.md) | [(0.9)](/filings/0001654954-26-004891.md) | [1.0](/filings/0001654954-26-007591.md) |
| Net income | $m | [0.9](/filings/0001654954-24-014468.md) | [(2.6) d](/filings/0001654954-25-012381.md) | [0.8](/filings/0001654954-25-013092.md) | [2.7](/filings/0001654954-25-013092.md) | [2.9](/filings/0001654954-25-013092.md) | [5.9 d](/filings/0001654954-26-003098.md) | [0.1](/filings/0001654954-26-007591.md) | [(1.7)](/filings/0001654954-26-007591.md) | [(0.3)](/filings/0001654954-25-013092.md) | [(8.5) d](/filings/0001654954-26-003098.md) | [(25.6)](/filings/0001654954-26-007591.md) | [17.5](/filings/0001654954-26-007591.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001654954-24-014468.md) | not reported | [0.01](/filings/0001654954-25-005762.md) | [0.03](/filings/0001654954-25-009652.md) | [0.03](/filings/0001654954-25-013092.md) | not reported | [0.03](/filings/0001654954-26-004891.md) | [(0.37)](/filings/0001654954-26-007591.md) | [0.00](/filings/0001654954-25-013092.md) | not reported | [(3.28)](/filings/0001654954-26-004891.md) | [1.31](/filings/0001654954-26-007591.md) |
| Basic EPS | $ per share | [0.01](/filings/0001654954-24-014468.md) | not reported | [0.01](/filings/0001654954-25-005762.md) | [0.03](/filings/0001654954-25-009652.md) | [0.03](/filings/0001654954-25-013092.md) | not reported | [0.03](/filings/0001654954-26-004891.md) | [(0.37)](/filings/0001654954-26-007591.md) | [0.00](/filings/0001654954-25-013092.md) | not reported | [(3.28)](/filings/0001654954-26-004891.md) | [1.31](/filings/0001654954-26-007591.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.2](/filings/0001654954-23-014022.md) | [18.5](/filings/0001654954-25-012381.md) | [13.3](/filings/0001654954-24-006414.md) | [6.1](/filings/0001654954-24-010652.md) | [4.6](/filings/0001654954-24-014468.md) | [4.0](/filings/0001654954-26-003098.md) | [10.4](/filings/0001654954-25-005762.md) | [8.5](/filings/0001654954-25-009652.md) | [10.9](/filings/0001654954-25-013092.md) | [3.2](/filings/0001654954-26-007591.md) | [7.7](/filings/0001654954-26-004891.md) | [10.8](/filings/0001654954-26-007591.md) |
| Current assets | $m | [19.2](/filings/0001654954-23-014022.md) | [24.6](/filings/0001654954-25-012381.md) | [20.3](/filings/0001654954-24-006414.md) | [15.1](/filings/0001654954-24-010652.md) | [11.0](/filings/0001654954-24-014468.md) | [13.2](/filings/0001654954-26-003098.md) | [23.6](/filings/0001654954-25-005762.md) | [17.6](/filings/0001654954-25-009652.md) | [16.2](/filings/0001654954-25-013092.md) | [37.8](/filings/0001654954-26-007591.md) | [42.5](/filings/0001654954-26-004891.md) | [39.8](/filings/0001654954-26-007591.md) |
| Total assets | $m | [111](/filings/0001654954-23-014022.md) | [123](/filings/0001654954-25-012381.md) | [118](/filings/0001654954-24-006414.md) | [111](/filings/0001654954-24-010652.md) | [114](/filings/0001654954-24-014468.md) | [128](/filings/0001654954-26-003098.md) | [146](/filings/0001654954-25-005762.md) | [137](/filings/0001654954-25-009652.md) | [136](/filings/0001654954-25-013092.md) | [376](/filings/0001654954-26-007591.md) | [370](/filings/0001654954-26-004891.md) | [360](/filings/0001654954-26-007591.md) |
| Current liabilities | $m | [5.3](/filings/0001654954-23-014022.md) | [18.9](/filings/0001654954-25-012381.md) | [15.5](/filings/0001654954-24-006414.md) | [5.1](/filings/0001654954-24-010652.md) | [5.2](/filings/0001654954-24-014468.md) | [6.9](/filings/0001654954-26-003098.md) | [16.9](/filings/0001654954-25-005762.md) | [10.6](/filings/0001654954-25-009652.md) | [14.6](/filings/0001654954-25-013092.md) | [64.5](/filings/0001654954-26-007591.md) | [63.0](/filings/0001654954-26-004891.md) | [50.7](/filings/0001654954-26-007591.md) |
| Total liabilities | $m | [8.6](/filings/0001654954-23-014022.md) | [21.3](/filings/0001654954-25-012381.md) | [18.3](/filings/0001654954-24-006414.md) | [7.8](/filings/0001654954-24-010652.md) | [7.8](/filings/0001654954-24-014468.md) | [12.7](/filings/0001654954-26-003098.md) | [23.9](/filings/0001654954-25-005762.md) | [16.2](/filings/0001654954-25-009652.md) | [20.5](/filings/0001654954-25-013092.md) | [169](/filings/0001654954-26-007591.md) | [188](/filings/0001654954-26-004891.md) | [160](/filings/0001654954-26-007591.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [102](/filings/0001654954-24-014468.md) | [101](/filings/0001654954-26-003098.md) | [100](/filings/0001654954-25-013092.md) | [103](/filings/0001654954-25-013092.md) | [107](/filings/0001654954-25-013092.md) | [116](/filings/0001654954-26-007591.md) | [116](/filings/0001654954-26-007591.md) | [115](/filings/0001654954-26-007591.md) | [115](/filings/0001654954-25-013092.md) | [207](/filings/0001654954-26-007591.md) | [182](/filings/0001654954-26-007591.md) | [200](/filings/0001654954-26-007591.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.1 d](/filings/0001654954-24-014468.md) | [12.1 d](/filings/0001654954-25-012381.md) | [(4.3)](/filings/0001654954-25-005762.md) | [4.6 d](/filings/0001654954-25-009652.md) | [8.3 d](/filings/0001654954-25-013092.md) | [4.2 d](/filings/0001654954-26-003098.md) | [5.9](/filings/0001654954-26-004891.md) | [(0.4) d](/filings/0001654954-26-007591.md) | [7.4 d](/filings/0001654954-25-013092.md) | [(2.1) d](/filings/0001654954-26-003098.md) | [10.5](/filings/0001654954-26-004891.md) | [15.3 d](/filings/0001654954-26-007591.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [85.6](/filings/0001654954-23-014022.md) | [86.7](/filings/0001654954-24-006414.md) | [87.0](/filings/0001654954-24-010652.md) | [87.1](/filings/0001654954-24-014468.md) | [88.8](/filings/0001654954-25-005762.md) | [89.3](/filings/0001654954-25-009652.md) | [89.4](/filings/0001654954-25-013092.md) | [4.5](/filings/0001654954-26-004891.md) | [4.6](/filings/0001654954-26-007591.md) | [92.2](/filings/0001654954-25-013092.md) | [7.8](/filings/0001654954-26-004891.md) | [13.3](/filings/0001654954-26-007591.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,290,902 at 2026-08-11, from the cover of the [10-Q filed 2026-08-13](/filings/0001654954-26-007591.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.